Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glivec in c-kit or PDGFR positive metastatic solid tumors
NCT00159016Phase 2Withdrawn
- Sponsor
- Hadassah Medical Organization
- Start
- Aug 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of imatinib in metastatic solid tumors, sponsored by Hadassah Medical Organization. Planned start Aug 2002; status: withdrawn.
02
Drugs
03
Conditions
metastatic solid tumors
Beyond the preview
Go deeper on NCT00159016.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00159016.